UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin’s Lymphoma

The New England journal of medicine, 2022-07, Vol.387 (4), p.310-320

2022

Volltextzugriff (PDF)

Prediction of clinical outcomes through assessment of sarcopenia and adipopenia using computed tomography in adult patients with acute myeloid leukemia

International journal of hematology, 2021-07, Vol.114 (1), p.44-52

2021

Volltextzugriff (PDF)

Guillain-Barré syndrome after vaccination against COVID-19

Lancet neurology, 2022-02, Vol.21 (2), p.117-119

2022

Volltextzugriff (PDF)

4-1BB immunotherapy: advances and hurdles

Experimental and Molecular Medicine, 2024, 56(0), , pp.32-39

2024

Volltextzugriff (PDF)

High level of pre-treatment C-reactive protein to albumin ratio predicts inferior prognosis in diffuse large B-cell lymphoma

Scientific reports, 2021-01, Vol.11 (1), p.2674-2674, Article 2674

2021

Volltextzugriff (PDF)

Elevated Red Blood Cell Distribution Width as a Simple Prognostic Factor in Patients with Symptomatic Multiple Myeloma

BioMed research international, 2014-01, Vol.2014 (2014), p.1-8

2014

Volltextzugriff (PDF)

Pomalidomide, cyclophosphamide, and dexamethasone for elderly patients with relapsed and refractory multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP‐164 study)

American journal of hematology, 2020-04, Vol.95 (4), p.413-421

2020

Volltextzugriff (PDF)

Analysis of laboratory parameters for optimal autologous peripheral blood stem cell collection from lymphoma and myeloma patients

Journal of clinical apheresis, 2021-02, Vol.36 (1), p.135-142

2021

Volltextzugriff (PDF)

Pretreatment C-reactive protein-to-albumin ratio predicts clinical outcomes in patients with peripheral T-cell lymphoma

International journal of hematology, 2023-02, Vol.117 (2), p.216-224

2023

Volltextzugriff (PDF)

Recent Clinical Update of Acute Myeloid Leukemia: Focus on Epigenetic Therapies

Journal of Korean Medical Science, 2021, 36(13), , pp.1-16

2021

Volltextzugriff (PDF)

Comparison of spectra optia and amicus cell separators for autologous peripheral blood stem cell collection

Journal of clinical apheresis, 2021-02, Vol.36 (1), p.28-33

2021

Volltextzugriff (PDF)

Characteristics and clinical outcome of high-risk multiple myeloma patients in Korea (KMM 1805)

International journal of hematology, 2022-07, Vol.116 (1), p.110-121

2022

Volltextzugriff (PDF)

First-Line Treatment for Primary Breast Diffuse Large B-Cell Lymphoma Using Immunochemotherapy and Central Nervous System Prophylaxis: A Multicenter Phase 2 Trial

Cancers, 2020-08, Vol.12 (8), p.2192

2020

Volltextzugriff (PDF)

Current Use of Total Body Irradiation in Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation

Journal of Korean Medical Science, 2021, 36(8), , pp.1-13

2021

Volltextzugriff (PDF)

Pralatrexate in patients with recurrent or refractory peripheral T-cell lymphomas: a multicenter retrospective analysis

Scientific reports, 2019-12, Vol.9 (1), p.20302-7, Article 20302

2019

Volltextzugriff (PDF)

Autologous stem cell transplantation in elderly patients with multiple myeloma in Korea: the KMM1807 study

International journal of hematology, 2020-07, Vol.112 (1), p.84-95

2020

Volltextzugriff (PDF)

Brief report: Clinical experiences after emergency use of daratumumab monotherapy for relapsed or refractory multiple myeloma in real practice

Japanese journal of clinical oncology, 2019-01, Vol.49 (1), p.92-95

2019

Volltextzugriff (PDF)

Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone

International journal of hematology, 2021, Vol.113 (1), p.81-91

2021

Volltextzugriff (PDF)

S311: EFFICACY OF INTRAVENOUS IRON TREATMENT FOR CANCER PATIENT WITH ANEMIA, RANDOMIZED CONTROLLED STUDY

HemaSphere, 2023-08, Vol.7 (S3), p.e1271871-n/a

2023

Volltextzugriff (PDF)

Rituximab plus multiagent chemotherapy for newly diagnosed CD20-positive acute lymphoblastic leukemia: a prospective phase II study

The Korean Journal of Internal Medicine, 2023, 38(5), , pp.734-746

2023

Volltextzugriff (PDF)

Carfilzomib in addition to lenalidomide and dexamethasone in Asian patients with RRMM outside of a clinical trial

Annals of hematology, 2021-08, Vol.100 (8), p.2051-2059

2021

Volltextzugriff (PDF)

Evaluation of the R2‐ISS in real‐world patients with newly diagnosed multiple myeloma: A nationwide cohort study by the Korean Multiple Myeloma Working Party (KMM 2202)

HemaSphere, 2024-01, Vol.8 (1), p.e33-n/a

2024

Volltextzugriff (PDF)

Phase I study of CKD-581, a pan-histone deacetylase inhibitor, in patients with lymphoma or multiple myeloma refractory to standard therapy

Investigational new drugs, 2018-10, Vol.36 (5), p.877-885

2018

Volltextzugriff (PDF)

Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantation

Frontiers in oncology, 2023-08, Vol.13, p.1230629-1230629

2023

Volltextzugriff (PDF)

Real‐world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis

Cancer communications (London, England), 2021-03, Vol.41 (3), p.275-278

2021

Volltextzugriff (PDF)

1 – 25 von 302

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(286)
Mit Volltextzugriff
(276)

Publikationsform

Sprache

Englisch
(281)
Koreanisch
(21)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin’s Lymphoma

Prediction of clinical outcomes through assessment of sarcopenia and adipopenia using computed tomography in adult patients with acute myeloid leukemia

Guillain-Barré syndrome after vaccination against COVID-19

4-1BB immunotherapy: advances and hurdles

High level of pre-treatment C-reactive protein to albumin ratio predicts inferior prognosis in diffuse large B-cell lymphoma

Elevated Red Blood Cell Distribution Width as a Simple Prognostic Factor in Patients with Symptomatic Multiple Myeloma

Pomalidomide, cyclophosphamide, and dexamethasone for elderly patients with relapsed and refractory multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP‐164 study)

Analysis of laboratory parameters for optimal autologous peripheral blood stem cell collection from lymphoma and myeloma patients

Pretreatment C-reactive protein-to-albumin ratio predicts clinical outcomes in patients with peripheral T-cell lymphoma

Recent Clinical Update of Acute Myeloid Leukemia: Focus on Epigenetic Therapies

Comparison of spectra optia and amicus cell separators for autologous peripheral blood stem cell collection

Characteristics and clinical outcome of high-risk multiple myeloma patients in Korea (KMM 1805)

First-Line Treatment for Primary Breast Diffuse Large B-Cell Lymphoma Using Immunochemotherapy and Central Nervous System Prophylaxis: A Multicenter Phase 2 Trial

Current Use of Total Body Irradiation in Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation

Pralatrexate in patients with recurrent or refractory peripheral T-cell lymphomas: a multicenter retrospective analysis

Autologous stem cell transplantation in elderly patients with multiple myeloma in Korea: the KMM1807 study

Brief report: Clinical experiences after emergency use of daratumumab monotherapy for relapsed or refractory multiple myeloma in real practice

Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone

S311: EFFICACY OF INTRAVENOUS IRON TREATMENT FOR CANCER PATIENT WITH ANEMIA, RANDOMIZED CONTROLLED STUDY

Rituximab plus multiagent chemotherapy for newly diagnosed CD20-positive acute lymphoblastic leukemia: a prospective phase II study

Carfilzomib in addition to lenalidomide and dexamethasone in Asian patients with RRMM outside of a clinical trial

Evaluation of the R2‐ISS in real‐world patients with newly diagnosed multiple myeloma: A nationwide cohort study by the Korean Multiple Myeloma Working Party (KMM 2202)

Phase I study of CKD-581, a pan-histone deacetylase inhibitor, in patients with lymphoma or multiple myeloma refractory to standard therapy

Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantation

Real‐world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis

Suchergebnisse filtern